PRS50 - COST-EFFECTIVENESS ANALYSIS OF SURFACTANT THERAPY FOR THE TREATMENT OF RESPIRATORY DISTRESS SYNDROME NEWBORN IN THE RUSSIAN FEDERATION
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2444
https://www.valueinhealthjournal.com/article/S1098-3015(18)35746-2/fulltext
Section Title :
Section Order :
1800
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35746-2&doi=10.1016/j.jval.2018.09.2444